3 research outputs found
Process Development and Scale-Up for the Preparation of the 1‑Methyl-quinazoline-2,4-dione Wnt Inhibitor SEN461
A practical
and scalable route to the Wnt inhibitor SEN461 <b>1</b> is described
herein. The optimized route consists of nine
chemical steps. The intermediates are solids and were isolated by
filtrations. Critical reactions steps in the medicinal chemistry route
were modified for an initial scale-up process, and as a result, we
developed a synthetic procedure for the preparation of multihundred
gram quantities of the final product. A further process development
for the phase 1 clinical batch campaign is reported
Development of a Scalable Route to the SMO Receptor Antagonist SEN794
A practical and scalable route to the SMO receptor antagonist
SEN794 <b>1</b> is described herein. A new and efficient access
to the key
intermediate <b>7</b> via the Kröhnke reaction was developed,
significantly simplifying the synthesis and reducing costs. The optimized
route consists of six chemical steps plus a palladium scavenging step.
The intermediates are solids and were isolated by filtrations, except
for ester <b>9</b>, which was telescoped as the crude oil into
the subsequent step. In the final amide formation step, target compound <b>1</b> was conveniently crystallized from the reaction mixture
in high purity
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation
In order to identify novel Alzheimer’s
modifying pharmacological
tools, we developed bis-tacrines bearing a peptide moiety for specific
interference with surface sites of <i>human</i> acetylcholinesterase
(<i>h</i>AChE) binding amyloid-beta (Aβ). Accordingly,
compounds <b>2a</b>–<b>c</b> proved to be inhibitors
of <i>h</i>AChE catalytic and noncatalytic functions, binding
the catalytic and peripheral sites, interfering with Aβ aggregation
and with the Aβ self-oligomerization process (<b>2a</b>). Compounds <b>2a</b>–<b>c</b> in complex with <i>Tc</i>AChE span the gorge with the bis-tacrine system, and the
peptide moieties bulge outside the gorge in proximity of the peripheral
site. These moieties are likely responsible for the observed reduction
of <i>h</i>AChE-induced Aβ aggregation since they
physically hamper Aβ binding to the enzyme surface. Moreover, <b>2a</b> was able to significantly interfere with Aβ self-oligomerization,
while <b>2b</b>,<b>c</b> showed improved inhibition of <i>h</i>AChE-induced Aβ aggregation